News

Initial Public Offering (IPO)

PepGen Goes Public in $108 Million IPO

Edward Kim | Equities.com |

The company is developing treatments for serious genetic diseases, with an initial focus on neuromuscular diseases.


Bausch + Lomb Raises $630 Million in IPO, Missing Expectations

Edward Kim | Equities.com |

The stock was priced at $18 per share, off a filing range of $21 - $24.


Blue Water Vaccines Raises $20 Million in Nasdaq IPO

Edward Kim | Equities.com |

The stock is expected to begin trading Friday under symbol BWV.


Sponsored Financial Content

Market Movers